CLH
Clean Harbors, Inc.
CLH has the edge over RKLB overall, supported by lower modeled downside and stronger fundamentals.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
CLH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
CLH's revenue, profitability, cash flow and balance sheet are all currently healthy.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CLH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $217 | -26% |
| Current | 30x | $294 | — |
| Forward | 30x | $294 | — |
| Fair | 31x | $307 | +4.3% |
| Expensive | 37x | $366 | +24% |
Historical ranges are pointers, not guarantees.
CLH's PE is in its fair range at 29.5x. On analysts' estimates for next year's earnings, today's price would be 30.2x.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
CLH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CLH, but weaker profitability. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over CLH on the outlook, with more favorable profitability expectations.
CLH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.74 | -2.3% |
| Q3 2026 | $9.96 | +38% |
| Q2 2026 | $8.24 | +16% |
| Q1 2026 | $7.38 | +2.2% |
| Q4 2025 | $7.28 | -1.9% |
| Q3 2025 | $7.21 | -6.1% |
| Q2 2025 | $7.12 | -1.7% |
| Q1 2025 | $7.22 | +4.5% |
| Q4 2024 | $7.42 | +6.8% |
CLH has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
CLH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +21% |
| Q2 2026 | $1.7B | +12% |
| Q1 2026 | $1.5B | +1.9% |
| Q4 2025 | $1.5B | +4.8% |
| Q3 2025 | $1.5B | +1.3% |
| Q2 2025 | $1.5B | -0.2% |
| Q1 2025 | $1.4B | +4% |
| Q4 2024 | $1.4B | +6.9% |
CLH's revenue has grown year over year for five quarters in a row: $1.9B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +4.6 points |
| Q2 2026 | 16% | +1.9 points |
| Q1 2026 | 8.2% | +0.4 points |
| Q4 2025 | 11% | +1 points |
| Q3 2025 | 12% | -0.1 points |
| Q2 2025 | 14% | -0.3 points |
| Q1 2025 | 7.8% | -1.3 points |
| Q4 2024 | 9.6% | -1.4 points |
CLH has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over CLH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
CLH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $246.4M | +19% |
| Q2 2026 | $113M | -4.3% |
| Q1 2026 | -$92.1M | +$24.9M |
| Q4 2025 | $233.3M | -3.4% |
| Q3 2025 | $207.5M | +46% |
| Q2 2025 | $118M | +46% |
| Q1 2025 | -$117.1M | +$2.3M |
| Q4 2024 | $241.5M | +43% |
CLH has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
CLH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -64K shares |
| 1 year | -1.5% | -816K shares |
| 3 years | -2.8% | -1.5M shares |
| 5 years | -3.3% | -1.8M shares |
| Available history | -5.8% | -3.2M shares |
CLH has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $27.1M |
| Q1 2026 | $25M |
| Q4 2025 | $133M |
| Q3 2025 | $50M |
| Q2 2025 | $12M |
| Q1 2025 | $55M |
| Q4 2024 | $25M |
CLH spent $210M buying back its own shares over the past year, up 48% from the year before.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CLH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.8x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 2.0x | Healthy |
CLH's net debt is about 1.9 years of its operating earnings (EBITDA), about the same as a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.6 | Neutral |
| Stochastic | 18.5 | Oversold |
CLH's weekly RSI is 46 (neutral) and its Stochastic is 19 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
CLH PE vs Industrials Sector
| Metric | CLH | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 24x | 23% above |
| PE % | 41 | 58 | 17 pts below |
CLH is trading at 30x earnings, a 23% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
CLH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $308.4 | 4.7% below |
| 20 week MA | $310.1 | 5.2% below |
| 50 week MA | $290.6 | 1.1% above |
| 100 week MA | $257.9 | 14% above |
| 200 week MA | $222.0 | 32% above |
CLH has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 32% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
CLH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $86.2 | $75.3 | -13% |
| 2021 | $75.3 | $95.6 | +27% |
| 2022 | $95.6 | $114.8 | +20% |
| 2023 | $114.8 | $174.5 | +52% |
| 2024 | $174.5 | $229.6 | +32% |
| 2025 | $229.6 | $240.8 | +4.9% |
| 2026 YTD | $240.8 | $293.8 | +22% |
CLH has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.